Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M O'Shea

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Practical Laboratory Medicine|September 1, 2017
Evaluating the optimum rest period prior to blood collection for fractionated plasma free metanephrines analysisT P Griffin, R Casey, D Wall, et al.
The Journal of Nutrition, Health & Aging|October 3, 2020
Establishing Benefit from Vitamin D Supplementation - Adherence to Defined Criteria and Targeting of High-Risk Groups Essential?S McGettigan, P Mulkerrin, P M O'Shea, et al.
Irish Medical Journal|June 29, 2017
Consider Beta-blocker withdrawal when using the Aldosterone Renin Ratio for case detection of Primary AldosteronismT P Griffin, D Wall, G A Browne, et al.
Annals of Clinical Biochemistry|August 18, 2017
Associations between glycaemic control and activation of the renin-angiotensin-aldosterone system in participants with type 2 diabetes mellitus and hypertensionT P Griffin, D Wall, G A Browne, et al.
Annals of Clinical Biochemistry|May 12, 2016
Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patientsR Casey, T P Griffin, D Wall, et al.
QJM : Monthly Journal of the Association of Physicians|May 16, 2020
Early gestational diabetes mellitus (GDM) is associated with worse pregnancy outcomes compared with GDM diagnosed at 24-28 weeks gestation despite early treatmentM Mustafa, D Bogdanet, A Khattak, et al.
Diabetes Research and Clinical Practice|April 28, 2022
Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: A systematic reviewC Newman, O Kgosidialwa, L Dervan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 14, 2021
A systematic review on outcome reporting in randomised controlled trials assessing treatment interventions in pregnant women with pregestational diabetesO Kgosidialwa, D Bogdanet, A Egan, et al.
Practical Laboratory Medicine|September 20, 2017
Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay systemP M O'Shea, T P Griffin, G A Browne, et al.
Diabetes Research and Clinical Practice|December 3, 2014
Glycaemic control is harder to achieve than blood pressure or lipid control in Irish adults with type 1 diabetesT G Cotter, S F Dinneen, D A Healy, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Practical Laboratory Medicine|September 1, 2017
Evaluating the optimum rest period prior to blood collection for fractionated plasma free metanephrines analysisT P Griffin, R Casey, D Wall, et al.
The Journal of Nutrition, Health & Aging|October 3, 2020
Establishing Benefit from Vitamin D Supplementation - Adherence to Defined Criteria and Targeting of High-Risk Groups Essential?S McGettigan, P Mulkerrin, P M O'Shea, et al.
Irish Medical Journal|June 29, 2017
Consider Beta-blocker withdrawal when using the Aldosterone Renin Ratio for case detection of Primary AldosteronismT P Griffin, D Wall, G A Browne, et al.
Annals of Clinical Biochemistry|August 18, 2017
Associations between glycaemic control and activation of the renin-angiotensin-aldosterone system in participants with type 2 diabetes mellitus and hypertensionT P Griffin, D Wall, G A Browne, et al.
Annals of Clinical Biochemistry|May 12, 2016
Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patientsR Casey, T P Griffin, D Wall, et al.
QJM : Monthly Journal of the Association of Physicians|May 16, 2020
Early gestational diabetes mellitus (GDM) is associated with worse pregnancy outcomes compared with GDM diagnosed at 24-28 weeks gestation despite early treatmentM Mustafa, D Bogdanet, A Khattak, et al.
Diabetes Research and Clinical Practice|April 28, 2022
Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: A systematic reviewC Newman, O Kgosidialwa, L Dervan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 14, 2021
A systematic review on outcome reporting in randomised controlled trials assessing treatment interventions in pregnant women with pregestational diabetesO Kgosidialwa, D Bogdanet, A Egan, et al.
Practical Laboratory Medicine|September 20, 2017
Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay systemP M O'Shea, T P Griffin, G A Browne, et al.
Diabetes Research and Clinical Practice|December 3, 2014
Glycaemic control is harder to achieve than blood pressure or lipid control in Irish adults with type 1 diabetesT G Cotter, S F Dinneen, D A Healy, et al.
Pageof 3